Relaxation of vascular smooth muscle by cicletanine in aged Wistar aorta under stress conditions: Importance of nitric oxide

American Journal of Hypertension

Volumn 13, Issue 2, 2000, Pages 208-213

  Chamiot Clerc, P ^a   Choukri, N ^a   Legrand, M ^b   Droy Lefaix, M T ^c   Safar, M E ^d   Renaud, J F ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b INSERM   (France)

^c IPSEN   (France)

^d HÔPITAL BROUSSAIS   (France)

Author keywords

Aorta; Cicletanine; Endothelium; Hypoxia

Indexed keywords

CICLETANINE; INDOMETACIN; NORADRENALIN;

ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; ENDOTHELIUM; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; STRESS; VASCULAR SMOOTH MUSCLE;

AGING; ANIMALS; ANOXIA; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INDOMETHACIN; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRIDINES; RATS; RATS, WISTAR; STRESS; VASODILATION;

EID: 0034049460     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00167-3     Document Type: Article

References (21)

1. Safar M., London G. The arterial system in hypertension. Swales J. Textbook of Hypertension. 1994;85-102 Blackwell Scientific Publications, London.
2. Collins R., Peto R., Mac Mahon S., et al. Blood pressure, stroke and coronary heart disease part 2: Short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context . Lancet. 335:1990;827-838.
3. Unwin R., Ligueros M., Shakelton C., et al. Diuretics in the management of hypertension. Laragh J., Brenner B. Hypertension, Pathophysiology, Diagnosis and Management. 1995;2785-2800 Raven Press, New York.
4. Tarazi R., Dustan H., Frolich E. Long-term thiazide therapy in essential hypertension evidence for persistent alteration in plasma volume and renin activity . Circulation. 41:1970;709-717.
5. Matrougi K., Schiavi P., Guez D., et al. High sodium intake decreases pressure-induced (myogenic) tone and flow induced dilation in resistance arteries from hypertensive rats. Hypertension. 32:1998;176-179.
6. Bourgain R., Deby C. Enhancement of prostacyclin generation by Cicletanine (an in vivo investigation). Drugs Exp Clin Res. 14:1988;135-139.
7. Garay R., Rosati C., Fanous K., et al. Evidence for (+) cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat. Eur J Pharmacol. 274:1995;175-180.
8. 1 receptors mediate phosphoinositide and calcium response in cultured smooth muscle cells. Interaction with cicletanine (CIC). Agents and Actions. 24:1988;255-260.
9. 2+-regulated protein kinases and relationship to vasorelaxation to cicletanine. J Pharmacol Exp Ther. 257:1990;382-386.
10. Buccholz R., Brousseau A., Silver P. Natriuretic and diuretic effects of cicletanine in conscious, hydrated, normotensive rats. Drug Dev Res. 25:1992;125-137.
11. Clostre F., Etienne A. General pharmacology of cicletanine. Drugs Exp Clin Res. 14:1988;73-82.
12. Simonet S., Bailliencourt de Porro J., Descombes J., et al. Hypoxia causes an abnormal contractile response in the atherosclerotic rabbit aorta. Implication of reduced nitric oxide and GMPc production. Circ Res. 72:1993;616-630.
13. Küng C., Lüscher T. Different mechanism of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 25:1995;194-200.
14. Jungers P. Pharmacokinetics of cicletanine in patients with impaired renal function. Drugs Exp Clin Res. 14:1988;189-194.
15. Fredj A. Clinical pharmacokinetics of cicletanine hydrochloride. Drugs Exp Clin Res. 14:1988;181-188.
16. Rubanyi G., Vanhoutte P. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol. 364:1985;45-56.
17. Bouthier J., Safar M., Deschamps E., et al. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension. Drugs Exp Clin Res. 14:1988;221-224.
18. Levy B., Curmi P., Poitevin P., et al. Modifications of the arterial mechanical properties of normotensive and hypertensive rats without arterial pressure changes. J Cardiovasc Pharmacol. 14:1989;253-259.
19. Koltai M., Esanu A., Braquet P. Relaxation of vascular smooth muscle by cicletanine. Importance of potassium channels and prostacyclin. Frölich J., Förstermann U. Clinical Pharmacology. 1990;106-136 W Zuckerschwerdt Verlag.
20. Rodman D., Yamaguchi T., O'Brien R., et al. Hypoxic contraction of isolated rat pulmonary artery. J Pharmacol Exp Ther. 248:1989;952-959.
21. 2 an endothelium-derived vasoconstrictor in human internal mammary arteries . Ann Thorac Surg. 56:1993;97-100.